UB Paderborn / Katalog / Suche / in CDI

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Volltextzugriff (PDF)

416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-81-S-81

2019

Volltextzugriff (PDF)

Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas

JGH open, 2019-06, Vol.3 (3), p.249-260

2019

Volltextzugriff (PDF)

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226

2019

Volltextzugriff (PDF)

Long‐term safety of vedolizumab for inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (8), p.1353-1365

2020

Volltextzugriff (PDF)

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

The New England journal of medicine, 2023-07, Vol.389 (4), p.309-321

2023

Volltextzugriff (PDF)

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

Gastroenterology (New York, N.Y. 1943), 2021-10, Vol.161 (4), p.1156-1167.e3

2021

Volltextzugriff (PDF)

Mo1653 - Safety and Efficacy of Local Injections of Mesenchymal Stem Cells in Perianal Fistula in Crohn's Disease: A Systematic Review and Meta-Analysis of the Clinical Trials and Observational Cohort Studies

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-784-S-785

2018

Volltextzugriff (PDF)

757 Histologic Improvement With Vedolizumab vs. Adalimumab in Ulcerative Colitis: Results From VARSITY

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S442-S442

2019

Volltextzugriff (PDF)

716 Early Clinical Response and Remission With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY

The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S421-S421

2019

Volltextzugriff (PDF)

835 – Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results from the Gemini Lts Study

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-182-S-182

2019

Volltextzugriff (PDF)

OP34 VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S612-S613

2019

Volltextzugriff (PDF)

Dr Foster's case notes: "Frequent flier" patients

BMJ. British medical journal (International ed.), 2005-04, Vol.330 (7496), p.869

International edition, 2005

Volltextzugriff (PDF)

"HRG drift" and payment by results

BMJ (Online), 2005-03, Vol.330 (7491), p.563

2005

Volltextzugriff (PDF)

Learning Retention Mechanisms and Evolutionary Parameters of Duplicate Genes from Their Expression Data

Molecular biology and evolution, 2021-03, Vol.38 (3), p.1209-1224

2021

Volltextzugriff (PDF)

Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors

American journal of transplantation, 2018-06, Vol.18 (6), p.1461-1470

2018

Volltextzugriff (PDF)

Advancing Environmental Epidemiology to Assess the Beneficial Influence of the Natural Environment on Human Health and Well-Being

Environmental science & technology, 2018-09, Vol.52 (17), p.9545-9555

2018

Volltextzugriff (PDF)

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Cancer discovery, 2020-03, Vol.10 (3), p.394-405

2020

Volltextzugriff (PDF)

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-09, Vol.320 (10), p.984

2018

Volltextzugriff (PDF)

Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome

The European journal of neuroscience, 2015-05, Vol.41 (10), p.1372-1380

2015

Volltextzugriff (PDF)

Neratinib protects pancreatic beta cells in diabetes

Nature communications, 2019-11, Vol.10 (1), p.5015-17, Article 5015

2019

Volltextzugriff (PDF)

HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction

Cardiovascular research, 2016-01, Vol.109 (1), p.115-130

2016

Volltextzugriff (PDF)

Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocols

Pediatric blood & cancer, 2023-07, Vol.70 (7), p.e30374-n/a

2023

Volltextzugriff (PDF)

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer

Cell reports (Cambridge), 2018-08, Vol.24 (6), p.1434-1444.e7

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

416a – Vedolizumab Shows Superior Efficacy Versus Adalimumab: Results of Varsity—The First Head-To-Head Study of Biologic Therapy for Moderate-To-Severe Ulcerative Colitis

Systematic review with meta‐analysis: Safety and efficacy of local injections of mesenchymal stem cells in perianal fistulas

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Long‐term safety of vedolizumab for inflammatory bowel disease

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

Mo1653 - Safety and Efficacy of Local Injections of Mesenchymal Stem Cells in Perianal Fistula in Crohn's Disease: A Systematic Review and Meta-Analysis of the Clinical Trials and Observational Cohort Studies

757 Histologic Improvement With Vedolizumab vs. Adalimumab in Ulcerative Colitis: Results From VARSITY

716 Early Clinical Response and Remission With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From VARSITY

835 – Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results from the Gemini Lts Study

OP34 VARSITY: A double-blind, double-dummy, randomised, controlled trial of vedolizumab versus adalimumab in patients with active ulcerative colitis

Dr Foster's case notes: "Frequent flier" patients

"HRG drift" and payment by results

Learning Retention Mechanisms and Evolutionary Parameters of Duplicate Genes from Their Expression Data

Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors

Advancing Environmental Epidemiology to Assess the Beneficial Influence of the Natural Environment on Human Health and Well-Being

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial

Reelin supplementation recovers synaptic plasticity and cognitive deficits in a mouse model for Angelman syndrome

Neratinib protects pancreatic beta cells in diabetes

HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction

Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocols

Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer

Suchergebnisse filtern